Literature DB >> 31642403

Impact of the NaV1.8 variant, A1073V, on post-sigmoidectomy pain and electrophysiological function in rat sympathetic neurons.

Matthew D Coates1, Joyce S Kim2, Nurgul Carkaci-Salli3, Kent E Vrana3, Walter A Koltun1, Henry L Puhl4, Sanjib D Adhikary5, Piotr K Janicki5, Victor Ruiz-Velasco5.   

Abstract

NaV1.8 channels play a crucial role in regulating the action potential in nociceptive neurons. A single nucleotide polymorphism in the human NaV1.8 gene SCN10A, A1073V (rs6795970, G>A), has been linked to the diminution of mechanical pain sensation as well as cardiac conduction abnormalities. Furthermore, studies have suggested that this polymorphism may result in a "loss-of-function" phenotype. In the present study, we performed genomic analysis of A1073V polymorphism presence in a cohort of patients undergoing sigmoid colectomy who provided information regarding perioperative pain and analgesic use. Homozygous carriers reported significantly reduced severity in postoperative abdominal pain compared with heterozygous and wild-type carriers. Homozygotes also trended toward using less analgesic/opiates during the postoperative period. We also heterologously expressed the wild-type and A1073V variant in rat superior cervical ganglion neurons. Electrophysiological testing demonstrated that the mutant NaV1.8 channels activated at more depolarized potentials compared with wild-type channels. Our study revealed that postoperative abdominal pain is diminished in homozygous carriers of A1073V and that this is likely due to reduced transmission of action potentials in nociceptive neurons. Our findings reinforce the importance of NaV1.8 and the A1073V polymorphism to pain perception. This information could be used to develop new predictive tools to optimize patient pain experience and analgesic use in the perioperative setting.NEW & NOTEWORTHY We present evidence that in a cohort of patients undergoing sigmoid colectomy, those homozygous for the NaV1.8 polymorphism (rs6795970) reported significantly lower abdominal pain scores than individuals with the homozygous wild-type or heterozygous genotype. In vitro electrophysiological recordings also suggest that the mutant NaV1.8 channel activates at more depolarizing potentials than the wild-type Na+ channel, characteristic of hypoactivity. This is the first report linking the rs6795970 mutation with postoperative abdominal pain in humans.

Entities:  

Keywords:  SCN10a polymorphism (rs6795970); postoperative pain management; whole cell patch clamp for NaV currents

Year:  2019        PMID: 31642403      PMCID: PMC6957366          DOI: 10.1152/jn.00542.2019

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  35 in total

1.  Voltage-clamp and current-clamp recordings from mammalian DRG neurons.

Authors:  Theodore R Cummins; Anthony M Rush; Mark Estacion; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  Nat Protoc       Date:  2009-07-09       Impact factor: 13.491

2.  Spinal sensory neurons express multiple sodium channel alpha-subunit mRNAs.

Authors:  J A Black; S Dib-Hajj; K McNabola; S Jeste; M A Rizzo; J D Kocsis; S G Waxman
Journal:  Brain Res Mol Brain Res       Date:  1996-12-31

3.  Loss-of-function of Nav1.8/D1639N linked to human pain can be rescued by lidocaine.

Authors:  Luisa Kaluza; Jannis E Meents; Martin Hampl; Corinna Rösseler; Petra A I Hautvast; Silvia Detro-Dassen; Ralf Hausmann; Günther Schmalzing; Angelika Lampert
Journal:  Pflugers Arch       Date:  2018-08-11       Impact factor: 3.657

4.  Epidural analgesia and postoperative lipid metabolism: stable isotope studies during a fasted/fed state.

Authors:  Franco Carli; R Lattermann; T Schricker
Journal:  Reg Anesth Pain Med       Date:  2002 Mar-Apr       Impact factor: 6.288

5.  A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons.

Authors:  A N Akopian; L Sivilotti; J N Wood
Journal:  Nature       Date:  1996-01-18       Impact factor: 49.962

6.  Common and rare variants in SCN10A modulate the risk of atrial fibrillation.

Authors:  Javad Jabbari; Morten S Olesen; Lei Yuan; Jonas B Nielsen; Bo Liang; Vincenzo Macri; Ingrid E Christophersen; Nikolaj Nielsen; Ahmad Sajadieh; Patrick T Ellinor; Morten Grunnet; Stig Haunsø; Anders G Holst; Jesper H Svendsen; Thomas Jespersen
Journal:  Circ Cardiovasc Genet       Date:  2015-02

7.  Complications in colorectal surgery: risk factors and preventive strategies.

Authors:  Philipp Kirchhoff; Pierre-Alain Clavien; Dieter Hahnloser
Journal:  Patient Saf Surg       Date:  2010-03-25

8.  Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.

Authors:  Jianying Huang; Yang Yang; Peng Zhao; Monique M Gerrits; Janneke G J Hoeijmakers; Kim Bekelaar; Ingemar S J Merkies; Catharina G Faber; Sulayman D Dib-Hajj; Stephen G Waxman
Journal:  J Neurosci       Date:  2013-08-28       Impact factor: 6.167

9.  A SCN10A SNP biases human pain sensitivity.

Authors:  Guangyou Duan; Chongyang Han; Qingli Wang; Shanna Guo; Yuhao Zhang; Ying Ying; Penghao Huang; Li Zhang; Lawrence Macala; Palak Shah; Mi Zhang; Ningbo Li; Sulayman D Dib-Hajj; Stephen G Waxman; Xianwei Zhang
Journal:  Mol Pain       Date:  2016-09-02       Impact factor: 3.395

10.  Homozygosity for the SCN10A Polymorphism rs6795970 Is Associated With Hypoalgesic Inflammatory Bowel Disease Phenotype.

Authors:  Eugene Gonzalez-Lopez; Yuka Imamura Kawasawa; Vonn Walter; Lijun Zhang; Walter A Koltun; Xuemei Huang; Kent E Vrana; Matthew D Coates
Journal:  Front Med (Lausanne)       Date:  2018-11-27
View more
  2 in total

Review 1.  Silent Inflammatory Bowel Disease.

Authors:  Matthew D Coates; David G Binion
Journal:  Crohns Colitis 360       Date:  2021-09-22

2.  Structural basis for high-voltage activation and subtype-specific inhibition of human Nav1.8.

Authors:  Xiaoshuang Huang; Xueqin Jin; Gaoxingyu Huang; Jian Huang; Tong Wu; Zhangqiang Li; Jiaofeng Chen; Fang Kong; Xiaojing Pan; Nieng Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-19       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.